AzurRx BioPharma to Participate in “Fireside Chat” at the H.C. Wainwright Global Life Sciences Conference

NEXT STORY
Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services
PREV STORY
G1 Therapeutics and Boehringer Ingelheim Announce Commercial Availability of COSELA™ (trilaciclib), the Only FDA-Approved Multilineage Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced Myelosuppression
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TLC Reports Last Patient Last Visit (LPLV) in TLC599 Phase II Trial and FDA Clearance to Commence New Clinical Trials

LPLV marks the final steps toward completion of TLC599 trial for osteoarthritis (OA) painPhase ...

author_avatar
NASDAQ Market News

GeoVax Labs, Inc. Announces Approval for Trading on OTCQB Venture Market

author_avatar
NASDAQ Market News

NANOBIOTIX half year results for the six months ended June 30, 2018

  Nanobiotix half year results for the six months ended June 30, 2018 Major milestones ...

author_avatar
NASDAQ Market News